nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—KDR—age related macular degeneration	0.792	1	CbGaD
Pazopanib—TAOK1—eye—age related macular degeneration	0.0035	0.0663	CbGeAlD
Pazopanib—SH2B3—eye—age related macular degeneration	0.0033	0.0624	CbGeAlD
Pazopanib—SH2B3—retina—age related macular degeneration	0.00327	0.0619	CbGeAlD
Pazopanib—LYN—connective tissue—age related macular degeneration	0.00267	0.0506	CbGeAlD
Pazopanib—FGFR3—connective tissue—age related macular degeneration	0.00266	0.0504	CbGeAlD
Pazopanib—FLT4—eye—age related macular degeneration	0.00215	0.0408	CbGeAlD
Pazopanib—PIP4K2C—retina—age related macular degeneration	0.00212	0.0402	CbGeAlD
Pazopanib—MAP3K2—connective tissue—age related macular degeneration	0.00196	0.0371	CbGeAlD
Pazopanib—FGF1—eye—age related macular degeneration	0.00191	0.0362	CbGeAlD
Pazopanib—FGF1—retina—age related macular degeneration	0.0019	0.0359	CbGeAlD
Pazopanib—FGF1—connective tissue—age related macular degeneration	0.00184	0.0349	CbGeAlD
Pazopanib—FGFR2—eye—age related macular degeneration	0.00181	0.0342	CbGeAlD
Pazopanib—FGFR2—connective tissue—age related macular degeneration	0.00174	0.033	CbGeAlD
Pazopanib—FLT1—eye—age related macular degeneration	0.00167	0.0317	CbGeAlD
Pazopanib—FLT1—retina—age related macular degeneration	0.00166	0.0314	CbGeAlD
Pazopanib—FLT1—connective tissue—age related macular degeneration	0.00161	0.0306	CbGeAlD
Pazopanib—TAOK3—eye—age related macular degeneration	0.00158	0.0299	CbGeAlD
Pazopanib—TAOK3—retina—age related macular degeneration	0.00156	0.0296	CbGeAlD
Pazopanib—TAOK3—connective tissue—age related macular degeneration	0.00152	0.0288	CbGeAlD
Pazopanib—PDGFRA—connective tissue—age related macular degeneration	0.00151	0.0286	CbGeAlD
Pazopanib—KDR—eye—age related macular degeneration	0.00142	0.0268	CbGeAlD
Pazopanib—KDR—retina—age related macular degeneration	0.0014	0.0266	CbGeAlD
Pazopanib—CSF1R—eye—age related macular degeneration	0.00138	0.0262	CbGeAlD
Pazopanib—KDR—connective tissue—age related macular degeneration	0.00136	0.0258	CbGeAlD
Pazopanib—CSF1R—connective tissue—age related macular degeneration	0.00133	0.0252	CbGeAlD
Pazopanib—PDGFRB—eye—age related macular degeneration	0.00123	0.0232	CbGeAlD
Pazopanib—KIT—connective tissue—age related macular degeneration	0.00121	0.0229	CbGeAlD
Pazopanib—PDGFRB—connective tissue—age related macular degeneration	0.00118	0.0224	CbGeAlD
Pazopanib—ABCB1—retina—age related macular degeneration	0.000337	0.00637	CbGeAlD
Pazopanib—KIT—Adaptive Immune System—C3—age related macular degeneration	4.31e-05	0.000278	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—CD36—age related macular degeneration	4.3e-05	0.000278	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—CRP—age related macular degeneration	4.27e-05	0.000275	CbGpPWpGaD
Pazopanib—FGFR2—Disease—TGFBR1—age related macular degeneration	4.26e-05	0.000275	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—C3—age related macular degeneration	4.26e-05	0.000275	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—C3—age related macular degeneration	4.24e-05	0.000274	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	4.19e-05	0.000271	CbGpPWpGaD
Pazopanib—KIT—Disease—TGFBR1—age related macular degeneration	4.19e-05	0.00027	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—SQSTM1—age related macular degeneration	4.19e-05	0.00027	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—TLR4—age related macular degeneration	4.16e-05	0.000269	CbGpPWpGaD
Pazopanib—KIT—Immune System—SQSTM1—age related macular degeneration	4.11e-05	0.000265	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ABCA4—age related macular degeneration	4.11e-05	0.000265	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—TLR4—age related macular degeneration	4.09e-05	0.000264	CbGpPWpGaD
Pazopanib—FGFR1—Adaptive Immune System—C3—age related macular degeneration	4.09e-05	0.000264	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—APOE—age related macular degeneration	4.08e-05	0.000264	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CD36—age related macular degeneration	4.08e-05	0.000263	CbGpPWpGaD
Pazopanib—PDGFRA—Adaptive Immune System—C3—age related macular degeneration	4.08e-05	0.000263	CbGpPWpGaD
Pazopanib—LYN—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	4.05e-05	0.000262	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—CRP—age related macular degeneration	4.05e-05	0.000261	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—CRP—age related macular degeneration	4.04e-05	0.000261	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—CD36—age related macular degeneration	4.04e-05	0.00026	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—KDR—age related macular degeneration	4e-05	0.000258	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CST3—age related macular degeneration	3.98e-05	0.000257	CbGpPWpGaD
Pazopanib—FGFR1—Disease—TGFBR1—age related macular degeneration	3.97e-05	0.000256	CbGpPWpGaD
Pazopanib—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	3.96e-05	0.000256	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—TGFBR1—age related macular degeneration	3.96e-05	0.000256	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—CD36—age related macular degeneration	3.95e-05	0.000255	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—SQSTM1—age related macular degeneration	3.94e-05	0.000254	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—SQSTM1—age related macular degeneration	3.9e-05	0.000252	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—SQSTM1—age related macular degeneration	3.89e-05	0.000251	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—TLR4—age related macular degeneration	3.88e-05	0.00025	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TGFBR1—age related macular degeneration	3.88e-05	0.00025	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD36—age related macular degeneration	3.88e-05	0.00025	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—TLR4—age related macular degeneration	3.87e-05	0.00025	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—KDR—age related macular degeneration	3.87e-05	0.00025	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—C3—age related macular degeneration	3.87e-05	0.00025	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—C3—age related macular degeneration	3.82e-05	0.000247	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD36—age related macular degeneration	3.79e-05	0.000245	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TGFBR1—age related macular degeneration	3.78e-05	0.000244	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—CCL2—age related macular degeneration	3.75e-05	0.000242	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—C3—age related macular degeneration	3.74e-05	0.000242	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—CRP—age related macular degeneration	3.68e-05	0.000237	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—C3—age related macular degeneration	3.67e-05	0.000237	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	3.66e-05	0.000237	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NMNAT1—age related macular degeneration	3.65e-05	0.000236	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—CRP—age related macular degeneration	3.64e-05	0.000235	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TGFBR1—age related macular degeneration	3.61e-05	0.000233	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—CD36—age related macular degeneration	3.6e-05	0.000232	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—C3—age related macular degeneration	3.6e-05	0.000232	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RHO—age related macular degeneration	3.57e-05	0.000231	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TGFBR1—age related macular degeneration	3.57e-05	0.00023	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—CRP—age related macular degeneration	3.56e-05	0.00023	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—TLR4—age related macular degeneration	3.53e-05	0.000228	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—SQSTM1—age related macular degeneration	3.52e-05	0.000227	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—SQSTM1—age related macular degeneration	3.51e-05	0.000226	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—TLR4—age related macular degeneration	3.49e-05	0.000225	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—VEGFA—age related macular degeneration	3.48e-05	0.000224	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	3.44e-05	0.000222	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—CCL2—age related macular degeneration	3.43e-05	0.000222	CbGpPWpGaD
Pazopanib—LYN—Immune System—SQSTM1—age related macular degeneration	3.43e-05	0.000222	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—SQSTM1—age related macular degeneration	3.43e-05	0.000221	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	3.43e-05	0.000221	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—TLR4—age related macular degeneration	3.41e-05	0.00022	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	3.4e-05	0.000219	CbGpPWpGaD
Pazopanib—FGFR1—Axon guidance—VEGFA—age related macular degeneration	3.39e-05	0.000219	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD36—age related macular degeneration	3.39e-05	0.000219	CbGpPWpGaD
Pazopanib—FGFR3—Disease—APOE—age related macular degeneration	3.32e-05	0.000214	CbGpPWpGaD
Pazopanib—LCK—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	3.32e-05	0.000214	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—VEGFA—age related macular degeneration	3.29e-05	0.000212	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	3.28e-05	0.000211	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—C3—age related macular degeneration	3.27e-05	0.000211	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—SQSTM1—age related macular degeneration	3.27e-05	0.000211	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—CD36—age related macular degeneration	3.24e-05	0.000209	CbGpPWpGaD
Pazopanib—FGF1—Immune System—C3—age related macular degeneration	3.21e-05	0.000207	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ELOVL4—age related macular degeneration	3.19e-05	0.000206	CbGpPWpGaD
Pazopanib—LCK—Disease—CST3—age related macular degeneration	3.19e-05	0.000206	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD36—age related macular degeneration	3.11e-05	0.000201	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—C3—age related macular degeneration	3.07e-05	0.000198	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CRP—age related macular degeneration	3.06e-05	0.000197	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—APOE—age related macular degeneration	3.05e-05	0.000197	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	3.02e-05	0.000195	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	3.01e-05	0.000194	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—KDR—age related macular degeneration	2.99e-05	0.000193	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TGFBR1—age related macular degeneration	2.99e-05	0.000193	CbGpPWpGaD
Pazopanib—LYN—Axon guidance—VEGFA—age related macular degeneration	2.99e-05	0.000193	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	2.95e-05	0.000191	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—C3—age related macular degeneration	2.95e-05	0.00019	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TGFBR1—age related macular degeneration	2.93e-05	0.000189	CbGpPWpGaD
Pazopanib—FGF1—Immune System—TLR4—age related macular degeneration	2.93e-05	0.000189	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—CRP—age related macular degeneration	2.92e-05	0.000188	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	2.92e-05	0.000188	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—LIPC—age related macular degeneration	2.87e-05	0.000185	CbGpPWpGaD
Pazopanib—LCK—Disease—TGFBR1—age related macular degeneration	2.87e-05	0.000185	CbGpPWpGaD
Pazopanib—LCK—Immune System—SQSTM1—age related macular degeneration	2.81e-05	0.000182	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD36—age related macular degeneration	2.81e-05	0.000181	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—TLR4—age related macular degeneration	2.8e-05	0.000181	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TGFBR1—age related macular degeneration	2.78e-05	0.00018	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TGFBR1—age related macular degeneration	2.78e-05	0.000179	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CETP—age related macular degeneration	2.77e-05	0.000179	CbGpPWpGaD
Pazopanib—FGF1—Disease—APOE—age related macular degeneration	2.76e-05	0.000178	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD36—age related macular degeneration	2.76e-05	0.000178	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	2.71e-05	0.000175	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—SQSTM1—age related macular degeneration	2.71e-05	0.000175	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—C3—age related macular degeneration	2.66e-05	0.000172	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—SQSTM1—age related macular degeneration	2.66e-05	0.000172	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—LIPC—age related macular degeneration	2.63e-05	0.00017	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD36—age related macular degeneration	2.62e-05	0.000169	CbGpPWpGaD
Pazopanib—KIT—Immune System—C3—age related macular degeneration	2.61e-05	0.000169	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD36—age related macular degeneration	2.61e-05	0.000168	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SLC16A8—age related macular degeneration	2.57e-05	0.000166	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—CCL2—age related macular degeneration	2.56e-05	0.000165	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	2.55e-05	0.000164	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CETP—age related macular degeneration	2.54e-05	0.000164	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CRP—age related macular degeneration	2.53e-05	0.000163	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—SQSTM1—age related macular degeneration	2.52e-05	0.000163	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—SQSTM1—age related macular degeneration	2.52e-05	0.000162	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TGFBR1—age related macular degeneration	2.5e-05	0.000161	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—C3—age related macular degeneration	2.5e-05	0.000161	CbGpPWpGaD
Pazopanib—KIT—Immune System—CRP—age related macular degeneration	2.48e-05	0.00016	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—C3—age related macular degeneration	2.48e-05	0.00016	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—C3—age related macular degeneration	2.47e-05	0.00016	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TGFBR1—age related macular degeneration	2.45e-05	0.000158	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—LIPC—age related macular degeneration	2.44e-05	0.000157	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—TLR4—age related macular degeneration	2.43e-05	0.000157	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	2.43e-05	0.000157	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—VEGFA—age related macular degeneration	2.42e-05	0.000156	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—VEGFA—age related macular degeneration	2.41e-05	0.000156	CbGpPWpGaD
Pazopanib—KIT—Immune System—TLR4—age related macular degeneration	2.38e-05	0.000154	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	2.36e-05	0.000152	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CRP—age related macular degeneration	2.36e-05	0.000152	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CRP—age related macular degeneration	2.35e-05	0.000152	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CETP—age related macular degeneration	2.35e-05	0.000152	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD36—age related macular degeneration	2.35e-05	0.000152	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—APOE—age related macular degeneration	2.33e-05	0.00015	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD36—age related macular degeneration	2.3e-05	0.000149	CbGpPWpGaD
Pazopanib—FGFR2—Disease—APOE—age related macular degeneration	2.29e-05	0.000148	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—KDR—age related macular degeneration	2.28e-05	0.000147	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	2.28e-05	0.000147	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—SQSTM1—age related macular degeneration	2.27e-05	0.000146	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—TLR4—age related macular degeneration	2.26e-05	0.000146	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—TLR4—age related macular degeneration	2.25e-05	0.000146	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	2.25e-05	0.000145	CbGpPWpGaD
Pazopanib—KIT—Disease—APOE—age related macular degeneration	2.24e-05	0.000145	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—C3—age related macular degeneration	2.23e-05	0.000144	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—C3—age related macular degeneration	2.23e-05	0.000144	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—SQSTM1—age related macular degeneration	2.22e-05	0.000143	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—VEGFA—age related macular degeneration	2.2e-05	0.000142	CbGpPWpGaD
Pazopanib—LYN—Immune System—C3—age related macular degeneration	2.18e-05	0.000141	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—C3—age related macular degeneration	2.18e-05	0.000141	CbGpPWpGaD
Pazopanib—FGFR1—Disease—APOE—age related macular degeneration	2.13e-05	0.000137	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—VEGFA—age related macular degeneration	2.13e-05	0.000137	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—APOE—age related macular degeneration	2.13e-05	0.000137	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CRP—age related macular degeneration	2.12e-05	0.000137	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—VEGFA—age related macular degeneration	2.09e-05	0.000135	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—APOE—age related macular degeneration	2.08e-05	0.000134	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—C3—age related macular degeneration	2.08e-05	0.000134	CbGpPWpGaD
Pazopanib—LYN—Immune System—CRP—age related macular degeneration	2.07e-05	0.000134	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	2.05e-05	0.000133	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—KDR—age related macular degeneration	2.04e-05	0.000132	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—TLR4—age related macular degeneration	2.03e-05	0.000131	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—APOE—age related macular degeneration	2.03e-05	0.000131	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TGFBR1—age related macular degeneration	2.01e-05	0.000129	CbGpPWpGaD
Pazopanib—LYN—Immune System—TLR4—age related macular degeneration	1.99e-05	0.000128	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	1.97e-05	0.000127	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	1.97e-05	0.000127	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CCL2—age related macular degeneration	1.96e-05	0.000126	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	1.96e-05	0.000126	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—APOE—age related macular degeneration	1.93e-05	0.000125	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—APOE—age related macular degeneration	1.91e-05	0.000124	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—KDR—age related macular degeneration	1.89e-05	0.000122	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD36—age related macular degeneration	1.89e-05	0.000122	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SQSTM1—age related macular degeneration	1.82e-05	0.000117	CbGpPWpGaD
Pazopanib—LCK—Immune System—C3—age related macular degeneration	1.79e-05	0.000115	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CCL2—age related macular degeneration	1.75e-05	0.000113	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	1.74e-05	0.000112	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—C3—age related macular degeneration	1.72e-05	0.000111	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—VEGFA—age related macular degeneration	1.71e-05	0.000111	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CCL2—age related macular degeneration	1.7e-05	0.00011	CbGpPWpGaD
Pazopanib—LCK—Immune System—CRP—age related macular degeneration	1.7e-05	0.00011	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—C3—age related macular degeneration	1.69e-05	0.000109	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CD36—age related macular degeneration	1.67e-05	0.000107	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—VEGFA—age related macular degeneration	1.64e-05	0.000106	CbGpPWpGaD
Pazopanib—LCK—Immune System—TLR4—age related macular degeneration	1.63e-05	0.000105	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CCL2—age related macular degeneration	1.63e-05	0.000105	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—C3—age related macular degeneration	1.6e-05	0.000103	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—APOE—age related macular degeneration	1.6e-05	0.000103	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—C3—age related macular degeneration	1.6e-05	0.000103	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	1.59e-05	0.000102	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—APOE—age related macular degeneration	1.57e-05	0.000101	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—KDR—age related macular degeneration	1.57e-05	0.000101	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—KDR—age related macular degeneration	1.54e-05	9.94e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—APOE—age related macular degeneration	1.54e-05	9.92e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CD36—age related macular degeneration	1.53e-05	9.85e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—LIPC—age related macular degeneration	1.51e-05	9.76e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—APOE—age related macular degeneration	1.49e-05	9.63e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—APOE—age related macular degeneration	1.49e-05	9.6e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—APOE—age related macular degeneration	1.47e-05	9.48e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—KDR—age related macular degeneration	1.46e-05	9.43e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CETP—age related macular degeneration	1.46e-05	9.42e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—KDR—age related macular degeneration	1.46e-05	9.41e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—C3—age related macular degeneration	1.44e-05	9.29e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CD36—age related macular degeneration	1.41e-05	9.12e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—C3—age related macular degeneration	1.41e-05	9.1e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	1.37e-05	8.84e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—APOE—age related macular degeneration	1.35e-05	8.69e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CCL2—age related macular degeneration	1.35e-05	8.68e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—APOE—age related macular degeneration	1.34e-05	8.65e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CCL2—age related macular degeneration	1.32e-05	8.53e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—LIPC—age related macular degeneration	1.32e-05	8.5e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—KDR—age related macular degeneration	1.31e-05	8.48e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—APOE—age related macular degeneration	1.31e-05	8.47e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—KDR—age related macular degeneration	1.29e-05	8.3e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CETP—age related macular degeneration	1.27e-05	8.2e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—VEGFA—age related macular degeneration	1.26e-05	8.11e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CCL2—age related macular degeneration	1.25e-05	8.09e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CCL2—age related macular degeneration	1.25e-05	8.07e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—APOE—age related macular degeneration	1.25e-05	8.04e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—LIPC—age related macular degeneration	1.24e-05	8.01e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	1.21e-05	7.8e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CETP—age related macular degeneration	1.2e-05	7.73e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—C3—age related macular degeneration	1.16e-05	7.46e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCL2—age related macular degeneration	1.13e-05	7.27e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—VEGFA—age related macular degeneration	1.12e-05	7.25e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCL2—age related macular degeneration	1.1e-05	7.12e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—VEGFA—age related macular degeneration	1.09e-05	7.06e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—APOE—age related macular degeneration	1.08e-05	6.94e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—KDR—age related macular degeneration	1.05e-05	6.8e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—LIPC—age related macular degeneration	1.05e-05	6.79e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—VEGFA—age related macular degeneration	1.04e-05	6.74e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CETP—age related macular degeneration	1.01e-05	6.55e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCL2—age related macular degeneration	9.04e-06	5.84e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CD36—age related macular degeneration	8.77e-06	5.66e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—age related macular degeneration	8.64e-06	5.58e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—age related macular degeneration	8.48e-06	5.48e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—LIPC—age related macular degeneration	8.12e-06	5.24e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—age related macular degeneration	8.05e-06	5.2e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—age related macular degeneration	8.03e-06	5.18e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CETP—age related macular degeneration	7.83e-06	5.05e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—APOE—age related macular degeneration	7.74e-06	4.99e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CD36—age related macular degeneration	7.64e-06	4.93e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—age related macular degeneration	7.24e-06	4.67e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CD36—age related macular degeneration	7.2e-06	4.65e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—age related macular degeneration	7.08e-06	4.57e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—APOE—age related macular degeneration	6.74e-06	4.35e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—APOE—age related macular degeneration	6.35e-06	4.1e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CD36—age related macular degeneration	6.1e-06	3.94e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—age related macular degeneration	5.81e-06	3.75e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—APOE—age related macular degeneration	5.38e-06	3.47e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CD36—age related macular degeneration	4.71e-06	3.04e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—APOE—age related macular degeneration	4.15e-06	2.68e-05	CbGpPWpGaD
